Press Releases Qiagen N.V. Swiss Exchange

Equities

QGEN

NL0015001WM6

Delayed Swiss Exchange Other stock markets 11:35:20 2019-06-28 am EDT			5-day change	1st Jan Change
39.45 ^CHF	+0.84%		-.--%	-.--%

Jun. 06	Qiagen Scraps NeuMoDx 96, 288 Molecular Systems; Raises 2024 Adjusted Earnings Outlook	MT
Jun. 06	Qiagen to Discontinue NeuMoDx Integrated PCR Testing System	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period	Jun. 06	AQ
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe	Jun. 05	AQ
Qiagen N : 2023 Annual Report Insights Magazine 2024	Jun. 03	PU
Qiagen N : 2023 Conflict mineral statement	Jun. 03	PU
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care	Jun. 03	AQ
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	May. 30	AQ
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine	May. 29	AQ
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	May. 14	AQ
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	May. 13	PU
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	May. 13	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	May. 08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	May. 08	PU
Qiagen N : Annual Report 2023, including the Reports of the Managing Board and the Supervisory Board of N.V.	May. 07	PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	May. 07	AQ
Qiagen N : Remuneration Report 2023	May. 06	PU
Qiagen N : Q1 2024 Results Investor Introduction	May. 03	PU
Qiagen N : Virtual Berenberg MDx Day Investor Introduction	May. 02	PU
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	May. 02	AQ
Qiagen N : First Quarter 2024 SEC Filing	May. 02	PU
Q1 2024 Results Conference Call Presentation: April 30, 2023	Apr. 30	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT